Domtar (NYSE:UFS) jumped the most it has in four years on news International Paper (NYSE:IP) is closing a mill in Alabama reducing North American capacity by at least 7%. Despite the big jump September 11, Domtar's stock is still in negative territory year-to-date. Is Domtar suddenly a buy?

Slow Progress

Three years ago I discussed the reasons why I thought Boston based Baupost Group's $225 million investment in Domtar would pan out for Baupost's billionaire founder, Seth Klarman. I reasoned that Klarman's second-quarter holdings report would shine a light on the direction of Domtar's stock: If he was still holding the 2.68 million shares it would demonstrate confidence in the company. Unfortunately, Baupost's Q2 holdings report showed the sale of 850,000 shares; another one million shares in the third quarter and the remaining 800,000 shares in the final three months of 2010. 

You can't blame Klarman for selling. By the end of 2010, Domtar stock was trading at $75.92, 25% above Baupost's break-even price of $60.82. Klarman had held Domtar stock for most of four years by the time he unloaded the remaining shares. Sure, it broke through the $100 mark five months later in 2011, but hindsight's 20/20.

Round Two

Put yourself in Klarman's shoes today. Would you buy at this point? For starters, the 7% reduction in the North American capacity for white paper, commonly used for copiers and printers, reduces the downward pressure on pricing at a time when demand continues to dwindle. This gives this part of Domtar's business a little breathing room.

Where the company has changed considerably is in its personal care segment, which didn't exist when Klarman exited at the end of 2010. In 2011, Domtar acquired Attends Healthcare, a manufacturer of adult incontinence products, for $315 million. It followed that up with two smaller acquisitions and then paid $272 million in May to buy Associated Hygienic Products, the largest supplier of store brand infant diapers in the U.S. Suddenly, its personal care segment was a real and growing part of its overall business. By 2017, it anticipates personal care will contribute $200 million in annualized EBITDA, representing one-third of its current EBITDA. By 2017, it wants to be generating between $300 million and $500 million annualized EBITDA from businesses that are growing like its personal care segment. While it might not generate nearly as much revenue as its paper business, it makes up for it by bringing the profits. And that's what's been lacking in recent years.  

Valuation

Domtar's current enterprise value is $2.8 billion, 4.8 times EBITDA. Its three peers: International Paper, MeadWestvaco (NYSE:MWV) and Weyerhaeuser (NYSE:WY) have an average multiple of 11.5, more than double Domtar. In terms of return on assets none of its peers are more profitable than Domtar and yet it's pulling up the rear. Another important metric is net debt as a multiple of EBITDA. Domtar's net debt position is $668 million or a multiple of one compared to an average of 2.7 times for its three peers. Procter & Gamble (NYSE:PG), the maker of Pampers, has an enterprise value of 12.7 times EBITDA. If Domtar's personal care segment hits its $200 million goal for annualized EBITDA by 2017, it will have an enterprise value equal to the entire company in 2013. Can you say spin-off? 

Bottom Line

While its last two quarterly reports are a very real reminder that Domtar's not out of the woods just yet, its free cash flow generation is so strong it's likely to continue growing its annual dividend payout, which currently sits at $2.20 yielding 3.1%—and that's after its 10% surge.

I see an undervalued stock that seems to be slowly getting itself ready to grow once more. Investors will eventually get on board; perhaps even Seth Klarman. Regardless of what he does, I think the 10% pop September 11 is just the beginning of a leg up to $90 and beyond. 

Should you buy? Definitely. 

Disclosure - At the time of writing, the author did not own shares of any company mentioned in this article.

Related Articles
  1. Stock Analysis

    Net Neutrality: Pros and Cons

    The fight over net neutrality has become an amazing spectacle. But at its core, it's yet another skirmish in cable television's war to remain relevant.
  2. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  3. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  4. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  5. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  6. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  7. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  8. Professionals

    What to do During a Market Correction

    The market has corrected...now what? Here's what you should consider rather than panicking.
  9. Mutual Funds & ETFs

    ETF Analysis: Vanguard Mid-Cap Value

    Take an in-depth look at the Vanguard Mid-Cap Value ETF, one of the largest and most popular mid-cap funds in the U.S. equity space.
  10. Mutual Funds & ETFs

    ETF Analysis: Schwab US Broad Market

    Take an in-depth look at the Schwab U.S. Broad Market ETF, an incredibly low-cost fund based on a wide selection of the U.S. equity market.
RELATED TERMS
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  3. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  4. Earnings Per Share - EPS

    The portion of a company's profit allocated to each outstanding ...
  5. PT (Perseroan Terbatas)

    An acronym for Perseroan Terbatas, which is Limited Liability ...
  6. Ltd. (Limited)

    An abbreviation of "limited," Ltd. is a suffix that ...
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

COMPANIES IN THIS ARTICLE
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!